13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060793
Total Value
$512.2M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,699,865 | $68.7M | 13.41% |
| 2 | COGENT BIOSCIENCES INC | COGT | 4,884,977 | $52.7M | 10.29% |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 2,214,142 | $48.5M | 9.47% |
| 4 | TERNS PHARMACEUTICALS INC | TERN | 3,619,522 | $42.9M | 8.37% |
| 5 | PLIANT THERAPEUTICS INC | PLRX | 1,430,000 | $38.0M | 7.43% |
| 6 | AMBRX BIOPHARMA INC | 02290A102 | 3,298,577 | $29.4M | 5.74% |
| 7 | GH RESEARCH PLC | GHRS | 3,517,125 | $28.1M | 5.49% |
| 8 | DICE THERAPEUTICS INC | 23345J104 | 819,000 | $23.5M | 4.58% |
| 9 | KALVISTA PHARMACEUTICALS INC | KALV | 2,916,667 | $22.9M | 4.48% |
| 10 | MERUS N V | N5749R100 | 1,226,214 | $22.6M | 4.41% |
| 11 | CELCUITY INC | CELC | 2,105,386 | $21.6M | 4.21% |
| 12 | AEROVATE THERAPEUTICS INC | 008064107 | 833,927 | $16.8M | 3.28% |
| 13 | CABALETTA BIO INC | CABA | 1,973,251 | $16.3M | 3.19% |
| 14 | VECTIVBIO HLDG AG | H9060V101 | 1,866,000 | $15.9M | 3.10% |
| 15 | ANNEXON INC | ANNX | 3,220,050 | $12.4M | 2.42% |
| 16 | SAVARA INC | SVRA | 6,351,531 | $12.4M | 2.42% |
| 17 | MILESTONE PHARMACEUTICALS IN | MIST | 2,208,812 | $8.7M | 1.70% |
| 18 | ACLARIS THERAPEUTICS INC | ACRS | 1,040,754 | $8.4M | 1.64% |
| 19 | THESEUS PHARMACEUTICALS INC | 88369M101 | 770,000 | $6.8M | 1.34% |
| 20 | TREVI THERAPEUTICS INC | TRVI | 3,050,022 | $5.6M | 1.10% |
| 21 | FULCRUM THERAPEUTICS INC | FULC | 1,307,094 | $3.7M | 0.73% |
| 22 | LYRA THERAPEUTICS INC | LYRA | 924,170 | $1.9M | 0.36% |
| 23 | AVALO THERAPEUTICS INC | AVTX | 1,000,000 | $1.8M | 0.34% |
| 24 | RALLYBIO CORP | RLYB | 268,532 | $1.5M | 0.30% |
| 25 | AFFIMED N V | N01045108 | 1,428,571 | $1.1M | 0.21% |